Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T D Gilmore

Oncogene

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Oncogene|December 22, 1999
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-RelT D Gilmore
Oncogene|October 31, 2006
Introduction to NF-kappaB: players, pathways, perspectivesT D Gilmore
Oncogene|October 31, 2006
Inhibitors of NF-kappaB signaling: 785 and countingT D Gilmore, M Herscovitch
Oncogene|December 22, 1999
Control of apoptosis by Rel/NF-kappaB transcription factorsM Barkett, T D Gilmore
Oncogene|March 1, 1993
v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequenceG Mosialos, T D Gilmore
Oncogene|August 1, 1993
Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domainS Sarkar, T D Gilmore
Oncogene|October 31, 2006
Mutations in the NF-kappaB signaling pathway: implications for human diseaseG Courtois, T D Gilmore
Oncogene|September 5, 1996
Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteinsD W White, T D Gilmore
Oncogene|December 1, 1991
Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding siteA J Capobianco, T D Gilmore
Oncogene|December 22, 1999
Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathwayJ C Epinat, T D Gilmore
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Oncogene|December 22, 1999
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-RelT D Gilmore
Oncogene|October 31, 2006
Introduction to NF-kappaB: players, pathways, perspectivesT D Gilmore
Oncogene|October 31, 2006
Inhibitors of NF-kappaB signaling: 785 and countingT D Gilmore, M Herscovitch
Oncogene|December 22, 1999
Control of apoptosis by Rel/NF-kappaB transcription factorsM Barkett, T D Gilmore
Oncogene|March 1, 1993
v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequenceG Mosialos, T D Gilmore
Oncogene|August 1, 1993
Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domainS Sarkar, T D Gilmore
Oncogene|October 31, 2006
Mutations in the NF-kappaB signaling pathway: implications for human diseaseG Courtois, T D Gilmore
Oncogene|September 5, 1996
Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteinsD W White, T D Gilmore
Oncogene|December 1, 1991
Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding siteA J Capobianco, T D Gilmore
Oncogene|December 22, 1999
Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathwayJ C Epinat, T D Gilmore
Pageof 2